Illumina, Inc.: Illumina Launches Research Test Codeveloped

New assay brings validated HRD technology from Myriad Genetics to the Illumina TruSight Oncology 500, a single, comprehensive pan-cancer test to identify key variants critical for cancer development

Related Keywords

Japan , United States , Canada , United Kingdom , Munich , Bayern , Germany , Erich Rubin , Technische Universit , Adi Raval , Phil Febbo , Nicole Pfarr , Instagram , Linkedin , Merck Research Laboratories , Twitter , Nasdaq , Research Use Only Trusight Oncology , Exchange Commission , Technical University Of Munich , Research Use , Youtube , Prnewswire Illumina Inc , Illumina Inc , Facebook , Myriad Geneticsto , Illumina Trusight Oncology , Trusight Oncology , Myriad Genetics , Molecular Pathology Diagnostic Unit , Technical University , Merck Research , Research Use Only , Tumor Mutational Burden , Microsatellite Instability , Homologous Recombination Deficiency , Illumina , Aunches , Research , Pest , Odeveloped , Merck , Unlock , Keeper , Insights , Humor , Enome ,